Novo Nordisk A/S, which is a world leading pharmaceutical company in diabetes and haemophilia care, made the investment for this new plant, which is located in Hillerod, in the Medicon Valley north of Copenhagen, Denmark. Novo Nordisk Engineering (nne), which is a leading engineering consulting company for the biotech and pharmaceutical industry, was the partner for BBI for the realization of this challenging project. BBI was selected as one main contractor for turnkey delivery of all process modules in the Fermentation medium and in the Fermentation area of the New Factor VII (NFVII) plant. BBI´s responsibility for the turnkey delivery of the majority and the most complex process modules in the NFVII plant covered everything, from detailed design and construction up to commissioning and qualification.

  Turnkey delivery of 12 process modules with total 26 process units
  Total 21 vessels ranging from 50l to 20.000l
  Total 61 sterile liquid and gas filters ranging from 5 to 30 filter cartridges
  Total 420 measurements
  Total 3000 I/O points
  Total 30 recipe procedures, using 100 operations and 120 phases
  Preparation of total 700 documents for Qualification
  Total 30.000 man hours for project management and engineering
  Total 27.000 man hours for commissioning and qualification